Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,166 across all filing types
Latest filing 2025-10-11 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI Listing Regulations, informing about a U.S. FDA Pre-Approval Inspection at a manufacturing facility. It is a regulatory announcement about an event (inspection and observation) rather than a financial report, management change, or other specific filings. The document is short (1894 characters) and serves as a compliance disclosure. It does not contain financial data, voting results, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-11 English
ESOP/ESOS/ESPS
Capital/Financing Update Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the grant of stock options to employees under various stock option plans. It details the number of options granted, the vesting schedule, and the entitlement upon vesting. This is a regulatory announcement about a share-based compensation event, specifically a stock option grant. It is not a full financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The content fits best under the category of Capital/Financing Update (CAP), as it relates to changes in the company's capital structure through stock options granted to employees.
2025-10-10 English
Intimation regarding grant of 14649 stock options under ESOP.
Regulatory Filings
2025-10-10 English
Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform.
Regulatory Filings
2025-10-09 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership program by Lupin Limited to expand the reach of its long-acting injectable platform. It is addressed to stock exchanges and references a disclosure pursuant to SEBI regulations. The content focuses on business strategy and partnership initiatives rather than financial results, regulatory filings, or management changes. It does not contain financial statements, voting results, or legal proceedings. The document is not a report but an announcement of a corporate development. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-10-09 English
Lupin Announces Plans to Build a New State-of-the-Art Manufacturing Facility in Coral Springs, Florida, U.S.A.
Regulatory Filings
2025-10-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.